Rituxan (rituximab) - Roche
doxorubicin hydrochloride - Generic mfg.
vincristine - Generic mfg.
cyclophosphamide - Generic mfg.
prednisone - Generic mfg.
Tubulointerstitial Nephritis Associated with IgG4-Related Disease (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-PO1157; Pres time: Oct 22, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Case Description Male patient, 75 years old, diagnosed with DLBCL, achieving complete remission in 2009 after treatment with R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine). Corticosteroid therapy (prednisone 40 mg/day) was initiated in February 2026, resulting in progressive improvement of Scr (1.3 mg/dL) after 2 weeks of therapy. Discussion Tubulointerstitial nephritis can be observed in up to 15% of IgG4-RD cases and should be included in the differential diagnosis in the context of mass-forming lesions and lymphadenopathies." 
B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Fibrosis • Hematological Malignancies • Immunology • Inflammation • Lymphoma • Nephrology • Non-Hodgkin's Lymphoma • Renal Disease
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4557721
 
Lucas Enock Vieira Roberto; Daniel Riva Bianchini; Felipe Lourenco Ledesma; Luciana Gil Lutf; Renato A. Caires; Francisco Zanotelli Mattedi; Liliana M L Kassar; Gabriela C. Segura; Wellington Silva; Veronica Torres Costa e Silva
 
Oct 2, 2026
 
Prev Next